"Takeda" の関連情報検索結果

FiercePharmaAsia—'Onshoring' drug manufacturing; Takeda's IBD pipeline cull; Legend's $350M IPO -...



FiercePharmaAsia—'Onshoring' drug manufacturing; Takeda's IBD pipeline cull; Legend's $350M IPO  FiercePharma

Takeda culls Shire pipeline med after no one wants it - FierceBiotech



Takeda culls Shire pipeline med after no one wants it  FierceBiotech

Takeda Pharma logs surprise profit, updates on COVID-19 therapy - Yahoo Finance



Takeda Pharma logs surprise profit, updates on COVID-19 therapy  Yahoo Finance

European Commission Releases Takeda From Commitment to Divest Shire's Pipeline Compound SHP647 - ...



European Commission Releases Takeda From Commitment to Divest Shire's Pipeline Compound SHP647  Business Wire

Takeda Offers Assurances on Natpara Supplies During Pandemic - Hypoparathyroidism News



Takeda Offers Assurances on Natpara Supplies During Pandemic  Hypoparathyroidism News

Takeda Pharmaceutical : New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Lo...



Takeda Pharmaceutical : New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Long-Term Safety and Efficacy of TAKHZYRO (lanadelumab) in Reducing Hereditary Angioedema Attacks  Marketscreener.com

U.S. FDA Approves Takeda's ALUNBRIG® (brigatinib) as a First-Line Treatment Option for Patients D...



U.S. FDA Approves Takeda's ALUNBRIG® (brigatinib) as a First-Line Treatment Option for Patients Diagnosed with Rare and Serious Form of Lung Cancer  Business Wire

Takeda warns of failures in COVID vaccine rush - Bioprocess Insider - BioProcess Insider



Takeda warns of failures in COVID vaccine rush - Bioprocess Insider  BioProcess Insider

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patie...



Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS  Business Wire

Takeda Gets EU Green Light to Keep Bowel Drug After Shire Buy - The New York Times



Takeda Gets EU Green Light to Keep Bowel Drug After Shire Buy  The New York Times

ASCO Highlights: Takeda, Genentech, Johnson & Johnson and More - BioSpace



ASCO Highlights: Takeda, Genentech, Johnson & Johnson and More  BioSpace

FiercePharmaAsia—Gilead's remdesivir licensing; Legend's $100M IPO; Takeda's blockbuster hopefuls...



FiercePharmaAsia—Gilead's remdesivir licensing; Legend's $100M IPO; Takeda's blockbuster hopefuls  FiercePharma

Takeda to present oncology pipeline data at upcoming virtual scientific congresses - News-Medical...



Takeda to present oncology pipeline data at upcoming virtual scientific congresses  News-Medical.Net

Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Can...



Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome  BioSpace

Takeda Supports IAEA Project Tackling COVID-19 Pandemic With €4.35 Million Donation - Internation...



Takeda Supports IAEA Project Tackling COVID-19 Pandemic With €4.35 Million Donation  International Atomic Energy Agency

Takeda gets expanded EC approval for lymphoma drug Adcetris - Pharmaceutical Business Review



Takeda gets expanded EC approval for lymphoma drug Adcetris  Pharmaceutical Business Review

Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Prac...



Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML  Business Wire

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelum...



Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks  Financial Post

Takeda closing in on COVID - Morgan County Citizen



Takeda closing in on COVID  Morgan County Citizen

Orifarm's $670 Million Acquisition Of Takeda Portfolio – Global Legal Chronicle - Global Legal Ch...



Orifarm's $670 Million Acquisition Of Takeda Portfolio – Global Legal Chronicle  Global Legal Chronicle

Mucopolysaccharidosis Treatment Market Is Booming Worldwide |Shire (Takeda Pharmaceutical Company...



Mucopolysaccharidosis Treatment Market Is Booming Worldwide |Shire (Takeda Pharmaceutical Company Limited), Denali Therapeutics, ArmaGen, REGENXBIO Inc., etc.  3rd Watch News

Takeda's Approval And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha



Takeda's Approval And Other News: The Good, Bad And Ugly Of Biopharma  Seeking Alpha

Takeda Sees Portfolio As Mostly Pandemic-Resistant - Scrip



Takeda Sees Portfolio As Mostly Pandemic-Resistant  Scrip

Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead - Endpoints News



Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead  Endpoints News

Takeda Pharmaceutical Company Limited (NYSE:TAK): An Opportunity for Fundamental Investors? - Sta...



Takeda Pharmaceutical Company Limited (NYSE:TAK): An Opportunity for Fundamental Investors?  State Reviewer

Biotech's biggest names take ‘unusual’ steps to create Covid-19 drugs - New York Business Journal



Biotech's biggest names take ‘unusual’ steps to create Covid-19 drugs  New York Business Journal

Takeda Pharmaceutical (TAK) Q4 2019 Earnings Call Transcript - Motley Fool



Takeda Pharmaceutical (TAK) Q4 2019 Earnings Call Transcript  Motley Fool

FiercePharmaAsia—CanSino's COVID-19 vaccine data; Takeda's new Alunbrig nod; GSK-Samsung deal - F...



FiercePharmaAsia—CanSino's COVID-19 vaccine data; Takeda's new Alunbrig nod; GSK-Samsung deal  FiercePharma

EU regulators allow Takeda to buy Shire without selling asset - Reuters



EU regulators allow Takeda to buy Shire without selling asset  Reuters

BRIEF-Takeda Announces Compelling Data From Phase 2 Trial Of Pevonedistat Plus Azacitidine In Pat...



BRIEF-Takeda Announces Compelling Data From Phase 2 Trial Of Pevonedistat Plus Azacitidine In Patients With Higher-Risk MDS  Reuters

Takeda Pharmaceutical : European Commission Approves Subcutaneous Entyvio for use as Maintenance ...



Takeda Pharmaceutical : European Commission Approves Subcutaneous Entyvio for use as Maintenance Therapy in Ulcerative Colitis or Crohn's Disease  Marketscreener.com

AZ, Takeda use different strategies on ovarian cancer - Korea Biomedical Review



AZ, Takeda use different strategies on ovarian cancer  Korea Biomedical Review

Telehealth giant raises $194M in funding - MedCity News



Telehealth giant raises $194M in funding  MedCity News

Teduglutide Drugs Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast t...



Teduglutide Drugs Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026|Takeda Pharmaceuticals, … ,  Jewish Life News

Factors That Could Influence Takeda Pharmaceutical Company Limited (NYSE:TAK) - State Reviewer



Factors That Could Influence Takeda Pharmaceutical Company Limited (NYSE:TAK)  State Reviewer

Antacid Market Research Report: Probable Key Development To Be Observed Market States And Outlook...



Antacid Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2026|AstraZeneca, Takeda Pharmaceutical, Pfizer  Jewish Life News

Takeda Pharmaceutical Company Limited (NYSE:TAK): A Fundamentally Weighted Stock for Long-Term In...



Takeda Pharmaceutical Company Limited (NYSE:TAK): A Fundamentally Weighted Stock for Long-Term Investors  State Reviewer

Gout Therapeutics Market Survey Report (COVID-19 impact) 2020-26: Takeda Pharmaceuticals, Horizon...



Gout Therapeutics Market Survey Report (COVID-19 impact) 2020-26: Takeda Pharmaceuticals, Horizon Pharma, Merck  Surfacing Magazine

Global Opioid-Induced Constipation Market 2020- Impact of COVID-19, Future Growth Analysis and Ch...



Global Opioid-Induced Constipation Market 2020- Impact of COVID-19, Future Growth Analysis and Challenges | Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health)  Surfacing Magazine

Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview Industry Demand, Development and Growth F...



Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview Industry Demand, Development and Growth Forecast Report 2026|Takeda Pharmaceuticals, … ,  Jewish Life News

COVID-19 Impact on Lisdexamfetamine Market Forecast to 2027 – Takeda - 3rd Watch News



COVID-19 Impact on Lisdexamfetamine Market Forecast to 2027 – Takeda  3rd Watch News

COVID-19 UPDATE : Antibody Drug Conjugates Market 2020 is Thriving Globally | By Leading Players ...



COVID-19 UPDATE : Antibody Drug Conjugates Market 2020 is Thriving Globally | By Leading Players Are...  Azizsalon News

Gastroesophageal Reflux Disease Therapeutics Market: What Will Industry Players Do to Boost Reven...



Gastroesophageal Reflux Disease Therapeutics Market: What Will Industry Players Do to Boost Revenue: AstraZeneca, Eisai, Takeda Pharmaceutical  Cole of Duty

Acromegaly Drug Market 2020 Global Industry Growth, Size, Share, Trends and Forecasts Report|Take...



Acromegaly Drug Market 2020 Global Industry Growth, Size, Share, Trends and Forecasts Report|Takeda Pharmaceutical Company Limited, Novartis AG, Chiasma  3rd Watch News

Covid-19 Impact on Global Teleconsultation Vehicle Market (2020-2026) | Potential growth, attract...



Covid-19 Impact on Global Teleconsultation Vehicle Market (2020-2026) | Potential growth, attractive valuation make it is a long-term investment | Top Players: Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, etc. | InForGrowth  Cole of Duty

Takeda will present data from the ICLUSIG® Clinical Trials Program (ponatinib), which may prove a...



Takeda will present data from the ICLUSIG® Clinical Trials Program (ponatinib), which may prove a change in practice for the treatment of chronic CML (chronic myeloid leukemia)  Explica

Central Nervous System Biomarkers Market Size, Trends and Industry Analysis 2026|Merck, Takeda Ph...



Central Nervous System Biomarkers Market Size, Trends and Industry Analysis 2026|Merck, Takeda Pharmaceutical, Thermo Fisher Scientific  Bulletin Line

Recombinant Plasma Proteins Market 2020– Industry Analysis, Size, Share, Trends, Market Demand, G...



Recombinant Plasma Proteins Market 2020– Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026, Research Report by QYResearch  Cole of Duty

Amwell confidentially files for IPO amid surging demand for remote health care - CNBC



Amwell confidentially files for IPO amid surging demand for remote health care  CNBC

Impact of COVID-19 On Thyroid Cancer Drugs Market to Witness Huge Growth: Vascular Biogenics, Aza...



Impact of COVID-19 On Thyroid Cancer Drugs Market to Witness Huge Growth: Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer, Eisai, Bio-Path Holdings, Takeda Pharmaceutical Company  Cole of Duty

Impact of COVID-19 Outbreak on Preventable Vaccines Market to Witness Astonishing Growth With- Gl...



Impact of COVID-19 Outbreak on Preventable Vaccines Market to Witness Astonishing Growth With- GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical  BіоPhаrmа Dіvе

Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Or...



Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD  BioSpace

Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021 - Fierce...



Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021  FiercePharma

Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morg...



Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference  Business Wire

Takeda, Snow Myeloma App 'Being Patient' Wins Pharma Choice Award - Myeloma Research News



Takeda, Snow Myeloma App 'Being Patient' Wins Pharma Choice Award  Myeloma Research News

Takeda and ProThera Enter Agreement to Develop Novel IAIP Therapy - BioSpace



Takeda and ProThera Enter Agreement to Develop Novel IAIP Therapy  BioSpace

(2020-2026) Phosphate Binding Agent Market Estimated To Experience A Hike in Growth | Global Indu...



(2020-2026) Phosphate Binding Agent Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue, Manufacturers  Cole of Duty

Takeda gets FDA breakthrough therapy for mobocertinib to treat NSCLC - Pharmaceutical Business Re...



Takeda gets FDA breakthrough therapy for mobocertinib to treat NSCLC  Pharmaceutical Business Review

Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Ye...



Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day  Business Wire

Horizon returns to Deerfield, buys former Takeda campus - Chicago Daily Herald



Horizon returns to Deerfield, buys former Takeda campus  Chicago Daily Herald

Albumin (as Excipient) Market Segmented by Product, Top Manufacturers, Geography Trends & Forecas...



Albumin (as Excipient) Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2026|CSL, Grifols, Takeda  Jewish Life News

Is Takeda Pharmaceutical Company Stock a Buy? - Motley Fool



Is Takeda Pharmaceutical Company Stock a Buy?  Motley Fool

Takeda Tells Employees To Work From Home - Contract Pharma



Takeda Tells Employees To Work From Home  Contract Pharma

Takeda R&D head: Drugmaker may not be a frontrunner, and that's OK - New York Business Journal



Takeda R&D head: Drugmaker may not be a frontrunner, and that's OK  New York Business Journal

Retinal Pharmaceuticals Market Research by Key players, Type and Application, Future Growth to 20...



Retinal Pharmaceuticals Market Research by Key players, Type and Application, Future Growth to 2026  3rd Watch News

Anti-Hypertensive Drugs Market Company Profiles, Financial Perspective 2026 - Cole of Duty



Anti-Hypertensive Drugs Market Company Profiles, Financial Perspective 2026  Cole of Duty

Takeda puts $120M in near-term cash on the table to complete a new oncology platform deal - Endpo...



Takeda puts $120M in near-term cash on the table to complete a new oncology platform deal  Endpoints News

Amwell files for IPO — report - Healthcare Dive



Amwell files for IPO — report  Healthcare Dive

Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process - BioPharma Dive



Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process  BioPharma Dive

(2020-2026) Diabetic Neurological Disorder Therapeutic Drug Market Is Booming Worldwide| Global I...



(2020-2026) Diabetic Neurological Disorder Therapeutic Drug Market Is Booming Worldwide| Global Industry Size, Growth, Segments, Revenue, Manufacturers  Cole of Duty

Coronavirus in Massachusetts: Takeda gives more than $6M to COVID-19 relief efforts - New York Bu...



Coronavirus in Massachusetts: Takeda gives more than $6M to COVID-19 relief efforts  New York Business Journal

As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines - The Japan Times



As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines  The Japan Times

Pediatric Vaccines Market Report Top-Companies Offerings And Market By End-User Segments Forecast...



Pediatric Vaccines Market Report Top-Companies Offerings And Market By End-User Segments Forecasted Till 2026  Cole of Duty

Multiple Myeloma Drugs Market: How Industry Giants Will Survive After COVID 19: Novartis, Bristol...



Multiple Myeloma Drugs Market: How Industry Giants Will Survive After COVID 19: Novartis, Bristol-Myers Squibb Company, Takeda Oncology  Bandera County Courier

Addison's Disease Drugs Market : Growth factor with key drivers, industry research, regional fore...



Addison's Disease Drugs Market : Growth factor with key drivers, industry research, regional forecast  3rd Watch News

Takeda donates more than $6 million to fight coronavirus - The Boston Globe



Takeda donates more than $6 million to fight coronavirus  The Boston Globe

Psychedelic Medicine and the Future of Mental Health Care Looks Promising - PRNewswire



Psychedelic Medicine and the Future of Mental Health Care Looks Promising  PRNewswire

Takeda, with US headquarters in Cambridge, says it’s working on a coronavirus treatment - The Bos...



Takeda, with US headquarters in Cambridge, says it’s working on a coronavirus treatment  The Boston Globe

J&J, Takeda cancel $400M surgical patch deal after antitrust scrutiny - MedTech Dive



J&J, Takeda cancel $400M surgical patch deal after antitrust scrutiny  MedTech Dive

Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evid...



Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment  Business Wire

Takeda licenses ProThera plasma drug for use in inflammatory conditions - FierceBiotech



Takeda licenses ProThera plasma drug for use in inflammatory conditions  FierceBiotech

Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Ca...



Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates  Associated Press

Japan's Takeda in push to debut COVID-19 treatment this year - Nikkei Asian Review



Japan's Takeda in push to debut COVID-19 treatment this year  Nikkei Asian Review

Should You Avoid Takeda Pharmaceutical Company Limited (TAK)? - Yahoo Finance



Should You Avoid Takeda Pharmaceutical Company Limited (TAK)?  Yahoo Finance

Takeda nets $940M from sales of U.S. HQ to Horizon, Latin American brands to Hypera - FiercePharma



Takeda nets $940M from sales of U.S. HQ to Horizon, Latin American brands to Hypera  FiercePharma

Takeda Adopts Executive Compensation Recoupment Policy - Business Wire



Takeda Adopts Executive Compensation Recoupment Policy  Business Wire

Takeda Invests in Patient-Centric Health Data Company Seqster - Clinical OMICs News



Takeda Invests in Patient-Centric Health Data Company Seqster  Clinical OMICs News

MIT School of Engineering and Takeda join to advance research in artificial intelligence and heal...



MIT School of Engineering and Takeda join to advance research in artificial intelligence and health  MIT News

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial - Business Wire



Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial  Business Wire

Takeda buys PvP in $330M deal to bag a 2nd celiac drug - FierceBiotech



Takeda buys PvP in $330M deal to bag a 2nd celiac drug  FierceBiotech

Ulcerative Colitis Market Rising Demand, Growth, Trend & Insights for next 6 years| AbbVie, Taked...



Ulcerative Colitis Market Rising Demand, Growth, Trend & Insights for next 6 years| AbbVie, Takeda Pharmaceutical Company, Bayer AG, UCB S.A., Perrigo Company , Pfizer  Surfacing Magazine

Takeda, drug maker with biggest head count in Mass., tells most employees to work from home - The...



Takeda, drug maker with biggest head count in Mass., tells most employees to work from home  The Boston Globe

Pharmaceutics and Novel Drug Delivery Systems Market 2020| Global Leading Players, Industry Updat...



Pharmaceutics and Novel Drug Delivery Systems Market 2020| Global Leading Players, Industry Updates, Future Growth, Business Prospects, Forthcoming Developments And Future Investments By Forecast To 2026  Cole of Duty

Preventable Vaccines Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countri...



Preventable Vaccines Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth  Cole of Duty

Takeda takes on the health of the planet - CSO Magazine - The Global CSR & Sustainability Platform



Takeda takes on the health of the planet  CSO Magazine - The Global CSR & Sustainability Platform

Horizon completes $115 million Takeda campus deal - Crain's Chicago Business



Horizon completes $115 million Takeda campus deal  Crain's Chicago Business

FiercePharmaAsia—Takeda-CSL coronavirus tie-up; Qiming's $1B VC fund; Fujifilm's Avigan COVID-19 ...



FiercePharmaAsia—Takeda-CSL coronavirus tie-up; Qiming's $1B VC fund; Fujifilm's Avigan COVID-19 trial  FiercePharma

Addison's Disease Therapeutics Market Innovative Strategy by 2025 | Bristol-Myers Squibb Merck No...



Addison's Disease Therapeutics Market Innovative Strategy by 2025 | Bristol-Myers Squibb Merck Novartis Pfizer Takeda Pharmaceutical Bio-Techne GlaxoSmithKline Lupin Pharmaceuticals Abbott Amgen Bayer Biogen Eli Lilly and Company Boehringer Ingelheim International Diurnal Switzer Life Science Recipharm  Cole of Duty

Takeda and Evotec Enter into Gene Therapy Research Alliance - BioSpace



Takeda and Evotec Enter into Gene Therapy Research Alliance  BioSpace

Takeda sees cell, gene therapy in its future. Is it too late? - BioPharma Dive



Takeda sees cell, gene therapy in its future. Is it too late?  BioPharma Dive